One in Four Deceased NFL Players Had CTE, Study Finds

At least one in four former National Football League (NFL) players who died between 2016 and 2021 exhibited signs of chronic traumatic encephalopathy (CTE), according to a retrospective study published in The American Journal of Pathology. This finding represents a significant increase compared to earlier estimates and highlights the pervasive nature of the neurodegenerative disease among professional American football players. The study analyzed brain tissue from 200 former NFL players who died between 2008 and 2021, with a specific focus on the period from 2016 to 2021 for the "one in four" statistic. Researchers identified CTE in 152 of the 200 players, equating to 76% of the total cohort. However, the study's authors, led by Dr. Michael Alosco from Boston University's CTE Center, emphasized that the sample was not representative of all NFL players, as it was drawn from a group of individuals whose families had donated their brains for research, suggesting a potential bias towards those with suspected neurological issues. Despite this caveat, the prevalence found in the more recent period (2016-2021) is particularly striking. The study detailed the severity of CTE, classifying it into four stages based on the accumulation of tau protein pathology. Stage 1, the mildest form, showed minimal tau buildup, while Stage 4 represented the most severe form, often associated with significant cognitive, behavioral, and mood symptoms. The research also explored potential risk factors, including the duration of a player's career and the position they played, though the specific findings on these factors were not detailed in the initial report. CTE is a progressive degenerative brain disease associated with repeated head trauma, including concussions and subconcussive hits. Symptoms can include memory loss, confusion, impaired judgment, impulse control problems, aggression, depression, and eventually progressive dementia. The study's methodology involved post-mortem examination of brain tissue, a gold standard for diagnosing CTE, which cannot be definitively diagnosed in living individuals. The findings underscore the urgent need for continued research into the prevention, diagnosis, and treatment of CTE, as well as for enhanced protective measures for athletes at all levels of play. The NFL has faced increasing scrutiny and litigation regarding its handling of player safety and the long-term health consequences of concussions. This study's results are likely to fuel further debate and advocacy for policy changes aimed at mitigating the risks associated with American football. The research builds upon previous work, including studies from Boston University, which have consistently shown high rates of CTE in former football players, but the specific statistic of "at least one in four" from the most recent period offers a stark new data point for public health officials and sports organizations to consider.